Literature DB >> 19524867

Relaxin and its role in the development and treatment of fibrosis.

Robert G Bennett1.   

Abstract

Relaxin, which is a peptide hormone of the insulin superfamily, is involved in the promotion of extracellular matrix remodeling. This property is responsible for many well-known reproductive functions of relaxin. Recent important findings, including the identification of the relaxin receptor and the development of the relaxin-null mouse, have identified new targets and mechanisms for relaxin's actions, which resulted in unprecedented advances in the field. Relaxin has emerged as a natural suppressor of age-related fibrosis in many tissues, which include the skin, lung, kidney, and heart. Furthermore, relaxin has shown efficacy in the prevention and treatment of a variety of models of experimentally induced fibrosis. The intention of this review is to present a summary of recent advances in relaxin research, with a focus on areas of potential translational research on fibrosis in nonreproductive organs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524867      PMCID: PMC2697124          DOI: 10.1016/j.trsl.2009.03.007

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  53 in total

1.  Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

Authors:  J R Seibold; J H Korn; R Simms; P J Clements; L W Moreland; M D Mayes; D E Furst; N Rothfield; V Steen; M Weisman; D Collier; F M Wigley; P A Merkel; M E Csuka; V Hsu; S Rocco; M Erikson; J Hannigan; W S Harkonen; M E Sanders
Journal:  Ann Intern Med       Date:  2000-06-06       Impact factor: 25.391

2.  Inhibition of markers of hepatic stellate cell activation by the hormone relaxin.

Authors:  Robert G Bennett; Kusum K Kharbanda; Dean J Tuma
Journal:  Biochem Pharmacol       Date:  2003-09-01       Impact factor: 5.858

3.  Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.

Authors:  S L Garber; Y Mirochnik; C S Brecklin; E N Unemori; A K Singh; L Slobodskoy; B H Grove; J A Arruda; G Dunea
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

4.  Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo.

Authors:  E J Williams; R C Benyon; N Trim; R Hadwin; B H Grove; M J Arthur; E N Unemori; J P Iredale
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

5.  The vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation: a morphologic study in the rat.

Authors:  D Bani; S Nistri; S Quattrone; M Bigazzi; T Bani Sacchi
Journal:  J Endocrinol       Date:  2001-12       Impact factor: 4.286

6.  Collagen studies in late pregnant relaxin null mice.

Authors:  L Zhao; C S Samuel; G W Tregear; F Beck; E M Wintour
Journal:  Biol Reprod       Date:  2000-09       Impact factor: 4.285

7.  Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2.

Authors:  Ishanee Mookerjee; Tim D Hewitson; Michelle L Halls; Roger J Summers; Michael L Mathai; Ross A D Bathgate; Geoffrey W Tregear; Chrishan S Samuel
Journal:  FASEB J       Date:  2008-12-10       Impact factor: 5.191

8.  Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.

Authors:  Rosemary Masterson; Tim D Hewitson; Kristen Kelynack; Marina Martic; Laura Parry; Ross Bathgate; Ian Darby; Gavin Becker
Journal:  Nephrol Dial Transplant       Date:  2004-03       Impact factor: 5.992

9.  Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways disease.

Authors:  Chrishan S Samuel; Simon G Royce; Bin Chen; Huifang Cao; Jan A Gossen; Geoffrey W Tregear; Mimi L K Tang
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

10.  Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis.

Authors:  Robert G Bennett; Dean G Heimann; Dean J Tuma
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

View more
  32 in total

Review 1.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 2.  Relaxin and fibrosis: Emerging targets, challenges, and future directions.

Authors:  Anthony J Kanai; Elisa M Konieczko; Robert G Bennett; Chrishan S Samuel; Simon G Royce
Journal:  Mol Cell Endocrinol       Date:  2019-02-14       Impact factor: 4.102

3.  Relaxin regulates myofibroblast contractility and protects against lung fibrosis.

Authors:  Xiangwei Huang; Ying Gai; Naiheng Yang; Baogen Lu; Chrishan S Samuel; Victor J Thannickal; Yong Zhou
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

Review 4.  The actions of relaxin on the human cardiovascular system.

Authors:  Mohsin Sarwar; Xiao-Jun Du; Thomas B Dschietzig; Roger J Summers
Journal:  Br J Pharmacol       Date:  2016-07-11       Impact factor: 8.739

5.  Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis.

Authors:  William A Blessing; Stephen M Okajima; M Belen Cubria; Juan C Villa-Camacho; Miguel Perez-Viloria; Patrick M Williamson; Angie N Sabogal; Sebastian Suarez; Lay-Hong Ang; Suzanne White; Evelyn Flynn; Edward K Rodriguez; Mark W Grinstaff; Ara Nazarian
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.

Authors:  Harinath Bahudhanapati; Jiangning Tan; Justin A Dutta; Stephen B Strock; John Sembrat; Diana Àlvarez; Mauricio Rojas; Benedikt Jäger; Antje Prasse; Yingze Zhang; Daniel J Kass
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

8.  Relaxin signaling activates peroxisome proliferator-activated receptor gamma.

Authors:  Sudhir Singh; Robert G Bennett
Journal:  Mol Cell Endocrinol       Date:  2009-08-25       Impact factor: 4.102

9.  Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.

Authors:  K P Patel; A S Giraud; C S Samuel; S G Royce
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

10.  Relaxin decreases the severity of established hepatic fibrosis in mice.

Authors:  Robert G Bennett; Dean G Heimann; Sudhir Singh; Ronda L Simpson; Dean J Tuma
Journal:  Liver Int       Date:  2013-07-21       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.